美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
64980-205-05	64980-205	HUMAN PRESCRIPTION DRUG	Lithium Carbonate	Lithium Carbonate	TABLET, EXTENDED RELEASE	ORAL	20160323	N/A	ANDA	ANDA204779	Rising Pharmaceuticals, Inc.	LITHIUM CARBONATE	300 mg/1	500 TABLET, EXTENDED RELEASE in 1 BOTTLE (64980-205-05)
64980-205-09	64980-205	HUMAN PRESCRIPTION DRUG	Lithium Carbonate	Lithium Carbonate	TABLET, EXTENDED RELEASE	ORAL	20160323	N/A	ANDA	ANDA204779	Rising Pharmaceuticals, Inc.	LITHIUM CARBONATE	300 mg/1	90 TABLET, EXTENDED RELEASE in 1 BOTTLE (64980-205-09)
70518-0608-0	70518-0608	HUMAN PRESCRIPTION DRUG	Lithium Carbonate	Lithium Carbonate	TABLET, EXTENDED RELEASE	ORAL	20170706	N/A	ANDA	ANDA204779	REMEDYREPACK INC.	LITHIUM CARBONATE	300 mg/1	30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70518-0608-0)
64980-205-03	64980-205	HUMAN PRESCRIPTION DRUG	Lithium Carbonate	Lithium Carbonate	TABLET, EXTENDED RELEASE	ORAL	20160323	N/A	ANDA	ANDA204779	Rising Pharmaceuticals, Inc.	LITHIUM CARBONATE	300 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (64980-205-03)
64980-205-01	64980-205	HUMAN PRESCRIPTION DRUG	Lithium Carbonate	Lithium Carbonate	TABLET, EXTENDED RELEASE	ORAL	20160323	N/A	ANDA	ANDA204779	Rising Pharmaceuticals, Inc.	LITHIUM CARBONATE	300 mg/1	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (64980-205-01)